ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech
LA-based biotech ImaginAb has signed a multi-party agreement with pharma giants AstraZeneca, Pfizer, and Takeda, for technology that allows scientists to see inside tumours, and monitor whether immunotherapies are taking effect.
ImaginAb’s imaging technology targets and visualises CD8+ T cells that are called in to attack tumours by immunotherapies.
Read more...